Therapure acquires chromatography tech in Upfront deal
Technology firm Upfront Chromatography has exited the biopharmaceutical manufacturing market after selling its protein purification business to Therapure Biopharma.
Archives for December 6, 2013
Norway to facilitate switch to biosimilars with $3m Remicade study
The Norwegian Health Department has committed 20m NOK ($3.3m) to a study in order to facilitate the use of biosimilars.
Cellexus claims new bioreactor better at mixing than rocking systems
Cellexus has launched a new bioreactor system that employs an air-based mixing system that is better at aerating cell cultures than rocking or large chamber systems.